S'abonner

The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial - 21/05/21

Doi : 10.1016/j.annemergmed.2020.12.013 
Adam Reuben, MB ChB a, , Andrew Appelboam, MBBS a, Kara N. Stevens, PhD b, Jane Vickery, PhD c, Paul Ewings, PhD d, e, Wendy Ingram, PhD c, Alison N. Jeffery, PhD c, Richard Body, PhD f, Malcolm Hilton, BM BCh a, Jason Coppell, MBBS a, Brian Wainman c, Andy Barton, PhD d
a Royal Devon and Exeter NHS Foundation Trust, Exeter, England 
b Medical Statistics Group, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth University, Plymouth, England 
c Peninsula Clinical Trials Unit, Faculty of Health, Medicine, Dentistry and Human Sciences, University of Plymouth University, Plymouth, England 
d National Institute of Health Research (NIHR) Research Design Service South West, United Kingdom 
e Taunton and Somerset NHS Foundation Trust, Taunton, Somerset, England 
f Division of Cardiovascular Science, The University of Manchester, Emergency Department, Manchester University NHS Foundation Trust, Manchester, England 

Corresponding Author.

Abstract

Study objective

Epistaxis is a common emergency department (ED) presentation and, if simple first aid measures fail, can lead to a need for anterior nasal packing. Tranexamic acid is an agent that contributes to blood clot stability. The aim of this study is to investigate the effectiveness of topical intranasal tranexamic acid in adult patients presenting to the ED with persistent epistaxis, and whether it reduces the need for anterior nasal packing.

Methods

From May 5, 2017, to March 31, 2019, a double-blind, placebo-controlled, multicenter, 1:1, randomized controlled trial was conducted across 26 EDs in the United Kingdom. Participants with spontaneous epistaxis, persisting after simple first aid and the application of a topical vasoconstrictor, were randomly allocated to receive topical tranexamic acid or placebo. The primary outcome was the need for anterior nasal packing of any kind during the index ED attendance. Secondary outcome measures included hospital admission, need for blood transfusion, recurrent epistaxis, and any thrombotic events requiring any hospital reattendance within 1 week.

Results

The study sample consisted of 496 participants with spontaneous epistaxis, persisting after simple first aid and application of a topical vasoconstrictor. In total, 211 participants (42.5%) received anterior nasal packing during the index ED attendance, including 111 of 254 (43.7%) in the tranexamic acid group versus 100 of 242 (41.3%) in the placebo group. The difference was not statistically significant (odds ratio 1.107; 95% confidence interval 0.769 to 1.594; P=.59). Furthermore, there were no statistically significant differences between tranexamic acid and placebo for any of the secondary outcome measures.

Conclusion

In patients presenting to an ED with atraumatic epistaxis that is uncontrolled with simple first aid measures, topical tranexamic acid applied in the bleeding nostril on a cotton wool dental roll is no more effective than placebo at controlling bleeding and reducing the need for anterior nasal packing.

Le texte complet de cet article est disponible en PDF.

Plan


 Please see page 632 for the Editor’s Capsule Summary of this article.
 Supervising editors: Michael Gottlieb, MD; Steven M. Green, MD. Specific detailed information about possible conflict of interest for individual editors is available at editors.
 Author contributions: AR, AA, JV, RB, MH, JC, and AB were responsible for the conception and design of this research. WI and ANJ contributed to protocol development. WI, ANJ, and BW undertook analysis and interpretation of data. KNS and PE were responsible for statistical data analysis. All authors contributed to the interpretation of the results, drafting and reviewing the article, and approval of the final version of the article. AR takes responsibility for the paper as a whole.
 All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. This study was funded by the National Institute for Health Research (NIHR) Research for Patient Benefit program (project reference PB PG 0215-36142).
 Trial registration number: ISRCTN34153772
 The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
 Readers: click on the link to go directly to a survey in which you can provide HJDSQ5S to Annals on this particular article.
 A podcast for this article is available at www.annemergmed.com.


© 2020  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 77 - N° 6

P. 631-640 - juin 2021 Retour au numéro
Article précédent Article précédent
  • Is the 4AT Score Accurate in Identifying Delirium in Older Adults?
  • Rachel E. Bridwell, Michael D. April, Brit Long
| Article suivant Article suivant
  • Lumbar Puncture Is Necessary for Ruling Out Atraumatic Subarachnoid Hemorrhage Six Hours After Symptom Onset
  • Michael D. April, Brit Long

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.